FDA Approves Voceryq for Recurrent Respiratory Papillomatosis
The FDA granted accelerated approval to Voceryq, the first plasmid DNA-based immunotherapy approved in the US for adult patients with recurrent respiratory papillomatosis (RRP).
The FDA granted accelerated approval to Voceryq, the first plasmid DNA-based immunotherapy approved in the US for adult patients with recurrent respiratory papillomatosis (RRP).
Long-term use of acid reflux drugs may raise the risk of severe respiratory complications and emergency care visits for asthma patients treated with biologics.
Pope Leo XIV has been diagnosed with lung cancer, after surgeons removed the lower lobe of the Pope’s right lung on Tuesday.
How a high-volume pediatric hospital implemented a collaborative protocol to improve pediatric asthma outcomes and reduce emergency department visits.
Patients with chronic bronchitis experienced better quality of life and fewer severe hospitalizations after Metered CryoSpray (MCS) therapy.
Wearable stickers can accurately measure sweat chloride levels in cystic fibrosis patients in under an hour without specialized laboratory equipment.
On World Interstitial Lung Disease Day, the American Lung Association launched an initiative to helping PPF patients and caregivers recognize worsening symptoms and lung scarring.
Researchers identified the factors that are most likely to create hazardous respiratory conditions inside homes after hurricane-related flooding.
Study shows immune responses to flu and COVID-19 trigger lasting inflammation in the spine, hastening onset/progression of amyotrophic lateral sclerosis (ALS).